US$ 22.47
pt141 spray nasal PT-141-Nasal PT-141 Bremelanotide Nasal Spray —
Description
Palatin initially tested an intranasal spray form of PT-141 in Phase II trials for men and women

They may ask if they can take a photograph to send to a specialist (dermatologist) to look at

This dose should be maintained for at least four weeks to assess tolerance and initial therapeutic response before considering further dose escalation

Individuals with multiple atypical nevi and a family history of melanoma have a 15% risk of developing melanoma

doi: 10.3390/medsci9040063

[Google Scholar] Binienda Z., Virmani A
